You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


Immunotherapy x

This October, Lokai adds to their collection of trademark bracelets by offering a limited-edition hot pink bracelet in support of BCRF. One dollar of each Breast Cancer Lokai purchased will support the Foundation’s mission to fund critical breast cancer research.

While much progress has been made in the treatment of breast cancer over the last 25 years, much work remains. New treatments are urgently needed for patients with metastatic breast cancer, triple-negative breast cancer and breast cancers that do not respond to currently available treatments, or

Dr. Annette Khaled is the Head of the Division of Cancer Research in the Burnett School of Biomedical Sciences of the College of Medicine at University of Central Florida, Orlando, FL.

As Cancer Immunotherapy Month passes, BCRF reviews the history of cancer immunotherapy, its recent advancements and its role in breast cancer treatment.

As tumors develop and grow, individual tumor cells acquire the ability to adapt to changes in the environment that would normally kill the tumor cells. One way they do this is to trick the immune system.

Triple negative breast cancer (TNBC) accounts for approximately 15 percent of all breast cancers.

Dr. Loi received her first BCRF research grant in 2014, but was no stranger to the BCRF researcher community.

In January of this year, the American Association for Cancer Research (AACR) released a special report outlining its view on how cancer prevention will change in the era of precision medicine and immune-oncology.

The 37th annual San Antonio Breast Cancer Symposium (SABCS) took place on December 9-13. The annual five-day program provides a forum for communication and education in breast cancer research.

Here at BCRF, we work hard to find and fund the most innovative minds in breast cancer research. Longstanding grantees Drs.